Skip to content

Comparative study of intravenous ketamine and tramadol for the prevention of shivering in parturients undergoing cesarean section under spinal anesthe

Efficacy intravenous tramadol and low dose ketamine in the prevention of post spinal anaesthesia shivering following cesarean section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201609001759210
Enrollment
123
Registered
2016-09-01
Start date
2016-09-05
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth Surgery cesarean section Anaesthesia

Interventions

Sponsors

University of gondar
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Parturients with ASA I physical status who will undergoing cesarean section under spinal anesthesia. 2. Parturients ASA II physical status II who will undergo cesarean section under spinal anesthesia.

Exclusion criteria

Exclusion criteria: 1. Patient refusal 2. Hyperthyroidism 3. Known allergic to opioids and ketamine 4. History of cardiopulmonary disease, hypertension 5. Psychotic patients patient diagnosed with antepartum hemorrhage, cord prolapse, fetal distress 6. Temperature >38oc or <36 oc 7. History of alcohol or substance abuse, 8. Those patients who needed blood transfusion during surgery or who received medications likely to alter thermoregulation (opoids) spinal anaesthesia with combination of intrathecal fentanyl. 9. Spinal anaesthesia with sedation like propofol, pethidine and ketamine, failed spinal converted to general anaesthesia.

Design outcomes

Primary

MeasureTime frame
reducing the incidence(%) of shivering following cesarean section under spinal anesthesia

Secondary

MeasureTime frame
unwanted effects of the prophylaxis

Countries

Ethiopia

Contacts

Public ContactYilkal Tadesse

University of Gondar

yilkaltadesse@yahoo.com+251-9-18-72-78-06

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026